Insider filing · SYRE
Sheldon Sloan
Chief Medical Officer
profile →
Spyre Therapeutics, Inc.
SYRE · Healthcare · 32 filings in 24 months
ticker →
Sheldon Sloan sold $5.6M of Spyre Therapeutics (SYRE)
Executed May 1, disclosed May 1, the same day.
Value, as filed
$5.6M
77,933 sh across 6 lots
Executed
May 1
the trade date, as filed
Disclosed
May 1
0 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
SSSheldon Sloan (Chief Medical Officer) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in Spyre Therapeutics, Inc. (SYRE). The largest single filing was $5.6M of SYRE (77,933 sh across 6 lots, as filed), executed May 1.
The name
SYREHealthcare · Spyre Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing therapeutics for patients living with inflammatory…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Sheldon Sloan in SYRE
SYRESALE
Spyre Therapeutics, Inc.
$731K8,334 sh across 2 lots
Exec Jul 1
Filed Jul 2 · 9:33 PM ET SYRESALE Spyre Therapeutics, Inc. $625K
8,333 sh × $75.00
Exec Jun 3
Filed Jun 3 · 5:30 PM ET SYRESALE Spyre Therapeutics, Inc. $398K
7,958 sh × $50.00
Exec Apr 1
Filed Apr 3 · 5:30 PM ET